Anzeige
Mehr »
Login
Donnerstag, 30.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Künstliche Intelligenz lässt die Nachfrage explodieren - so profitieren Anleger
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3E19Y | ISIN: BE0974461940 | Ticker-Symbol:
Lang & Schwarz
29.05.24
07:00 Uhr
2,995 Euro
0,000
0,00 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
MDXHEALTH SA Chart 1 Jahr
5-Tage-Chart
MDXHEALTH SA 5-Tage-Chart
RealtimeGeldBriefZeit
2,9553,03529.05.

Aktuelle News zur MDXHEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
16.05.MDxHealth SA - 6-K, Report of foreign issuer1
01.05.MDxHealth SA GAAP EPS of -$0.31, revenue of $19.8M1
01.05.MDxHealth SA - 6-K, Report of foreign issuer1
01.05.MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed124MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed Year-over-year Q1 revenues increase by 35% to $19.8 millionIncreasing 2024 revenue guidance to $83-85 million, previously...
► Artikel lesen
12.03.MDxHealth expands prostate cancer test portfolio3
12.03.MDxHealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering106Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering IRVINE, CA, and HERSTAL, BELGIUM - March 12, 2024 (GlobeNewswire) - MDxHealth SA (NASDAQ: MDXH) (the "Company" or...
► Artikel lesen
07.03.These Analysts Increase Their Forecasts On MDxHealth After Q4 Results1
06.03.MDxHealth SA reports results for the quarter ended in December - Earnings Summary-
06.03.MDxHealth SA - 6-K, Report of foreign issuer1
06.03.MDxHealth SA GAAP EPS of -$0.39 misses by $0.08, revenue of $19.39M beats by $0.46M1
06.03.MDxHealth Announces Fourth Quarter and Full-Year 2023 Financial Results64Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results 2023 revenue grew by 89% to $70.2 million; excluding GPS, revenues up 42%2023 gross margin expanded by 10.7 percentage points...
► Artikel lesen
21.02.MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 61
16.02.MDxHealth SA - 6-K, Report of foreign issuer1
16.02.Board member Jan Pensaert exits MDxHealth1
16.02.Mdxhealth Announces Resignation of Board Member2
09.01.MDxHealth gains as prelim Q4 revenue beats estimates2
08.01.MDxHealth rises as prelim Q4 revenue beats estimates1
08.01.MDxHealth provides Q4 expectation, issues 2024 guidance1
08.01.MDxHealth SA - 6-K, Report of foreign issuer1
08.01.MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance196MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance IRVINE, CA, and HERSTAL, BELGIUM - January 8, 2024 (GlobeNewswire) - MDxHealth...
► Artikel lesen
Seite:  Weiter >>
40 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1